当前位置:首页 - 行情中心 - 民生健康(301507) - 财务分析 - 利润表

民生健康

(301507)

  

流通市值:15.39亿  总市值:49.85亿
流通股本:1.10亿   总股本:3.57亿

利润表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、营业总收入317,485,567.9781,631,352.96622,651,417.8462,484,278.99
  营业收入317,485,567.9781,631,352.96622,651,417.8462,484,278.99
二、营业总成本237,413,026.45686,772,522.22527,856,658.74374,222,899.02
  营业成本134,055,835.09382,223,906.91298,329,601.69211,115,711.95
  税金及附加3,665,799.516,947,157.435,711,631.64,463,099.93
  销售费用76,352,886.46215,255,780.53163,207,842.61119,310,534.37
  管理费用16,488,205.5765,287,635.7745,356,652.927,853,003.56
  研发费用8,665,653.5726,079,557.2622,269,360.716,268,524.9
  财务费用-1,815,353.75-9,021,515.68-7,018,430.76-4,787,975.69
  其中:利息费用43,221.8356,736.64-41,409.03
  其中:利息收入1,877,512.379,221,295.027,172,851.924,892,920.33
三、其他经营收益
  加:公允价值变动收益-4,102,396.0423,878,016.4326,960,798.37-252,364.9
  加:投资收益1,320,235.5712,874,862.439,582,086.087,457,673
  资产处置收益-207,860.26-3,001.28-3,001.289,264.26
  资产减值损失(新)-640,349.17-1,873,435.28-1,997,638.55-2,159,067.56
  信用减值损失(新)-1,773,596.531,353,561.636,656.46-121,960.86
  其他收益1,136,734.416,072,932.83,349,593.322,698,771.88
四、营业利润75,805,309.43137,161,767.44132,723,253.4695,893,695.79
  加:营业外收入5,805.39467,354.47251,011.82171,765.04
  减:营业外支出11,666.27145,688.3382,462.3331,893.55
五、利润总额75,799,448.55137,483,433.58132,891,802.9596,033,567.28
  减:所得税费用12,836,978.9216,435,971.117,807,00013,432,326.22
六、净利润62,962,469.63121,047,462.48115,084,802.9582,601,241.06
(一)按经营持续性分类
  持续经营净利润62,962,469.63121,047,462.48115,084,802.9582,601,241.06
(二)按所有权归属分类
  归属于母公司股东的净利润62,778,343.85118,791,692.72114,416,51482,405,120.58
  少数股东损益184,125.782,255,769.76668,288.95196,120.48
  扣除非经常损益后的净利润66,539,232.1492,043,576.1387,969,854.4579,328,679.2
七、每股收益
  (一)基本每股收益0.180.330.320.23
  (二)稀释每股收益0.180.330.320.23
九、综合收益总额62,962,469.63121,047,462.48115,084,802.9582,601,241.06
  归属于母公司股东的综合收益总额62,778,343.85118,791,692.72114,416,51482,405,120.58
  归属于少数股东的综合收益总额184,125.782,255,769.76668,288.95196,120.48
公告日期2026-04-242026-04-242025-10-302025-08-26
审计意见(境内)标准无保留意见
TOP↑